| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |